Allochromenone inhibitors of phosphoinositide 3-kinase (PI3K) for treatment of diseases associated with PI3K modulation
The present disclosure relates to compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, W, X, Y, s and ring A are as described herein, or prodrugs, solvates, enantiomers, stereoisomers, tautomers or pharmaceutically acceptable salts thereof, as allochromenone inhibitors of phosphoino...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure relates to compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, W, X, Y, s and ring A are as described herein, or prodrugs, solvates, enantiomers, stereoisomers, tautomers or pharmaceutically acceptable salts thereof, as allochromenone inhibitors of phosphoinositide 3-kinase (PI3K), useful in the treatment of diseases or disorders associated with PI3K modulation.
本公开内容涉及可用于治疗与PI3K调节相关的疾病或障碍的作为磷酸肌醇3-激酶(PI3K)的变构色烯酮抑制剂的式(I)的化合物或其前药、溶剂化物、对映异构体、立体异构体、互变异构体或药学上可接受的盐,,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、W、X、Y、s和环A如本文中所述。 |
---|